Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H18N2 |
| Molecular Weight | 250.3382 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1CN2C(CN1)C3=CC=CC=C3CC4=CC=CC=C24
InChI
InChIKey=ZBILSSSEXRZGKS-UHFFFAOYSA-N
InChI=1S/C17H18N2/c1-3-7-15-13(5-1)11-14-6-2-4-8-16(14)19-10-9-18-12-17(15)19/h1-8,17-18H,9-12H2
| Molecular Formula | C17H18N2 |
| Molecular Weight | 250.3382 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:38:32 GMT 2025
by
admin
on
Mon Mar 31 23:38:32 GMT 2025
|
| Record UNII |
PI2H4ADR4C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
71936-92-0
Created by
admin on Mon Mar 31 23:38:32 GMT 2025 , Edited by admin on Mon Mar 31 23:38:32 GMT 2025
|
PRIMARY | |||
|
DTXSID20891477
Created by
admin on Mon Mar 31 23:38:32 GMT 2025 , Edited by admin on Mon Mar 31 23:38:32 GMT 2025
|
PRIMARY | |||
|
PI2H4ADR4C
Created by
admin on Mon Mar 31 23:38:32 GMT 2025 , Edited by admin on Mon Mar 31 23:38:32 GMT 2025
|
PRIMARY | |||
|
115194
Created by
admin on Mon Mar 31 23:38:32 GMT 2025 , Edited by admin on Mon Mar 31 23:38:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
The plasma concentration of the compound was within the predicted therapeutic range in only 43% of patients.
AMOUNT ADMINISTERED
PLASMA
|
